Journal Article

Roquin1 inhibits the proliferation of breast cancer cells by inducing G1/S cell cycle arrest via selectively destabilizing the mRNAs of cell cycle–promoting genes

Wang, Bing, Li, Bingwei, Lu, Wenbao, Liu, Xueting, Zhou, Meicen

2020

Overview

Background Dysregulation of cell cycle progression is a common feature of human cancer cells; however, its mechanism remains unclear. This study aims to clarify the role and the underlying mechanisms of Roquin1 in cell cycle arrest in breast cancer. Methods Public cancer databases were analyzed to identify the expression pattern of Roquin1 in human breast cancers and its association with patient survival. Quantitative real-time PCR and Western blots were performed to detect the expression of Roquin1 in breast cancer samples and cell lines. Cell counting, MTT assays, flow cytometry, and in vivo analyses were conducted to investigate the effects of Roquin1 on cell proliferation, cell cycle progression and tumor progression. RNA sequencing was applied to identify the differentially expressed genes regulated by Roquin1. RNA immunoprecipitation assay, luciferase reporter assay, mRNA half-life detection, RNA affinity binding assay, and RIP-ChIP were used to explore the molecular mechanisms of Roquin1. Results We showed that Roquin1 expression in breast cancer tissues and cell lines was inhibited, and the reduction in Roquin1 expression was associated with poor overall survival and relapse-free survival of patients with breast cancer. Roquin1 overexpression inhibited cell proliferation and induced G1/S cell cycle arrest without causing significant apoptosis. In contrast, knockdown of Roquin1 promoted cell growth and cycle progression. Moreover, in vivo induction of Roquin1 by adenovirus significantly suppressed breast tumor growth and metastasis. Mechanistically, Roquin1 selectively destabilizes cell cycle–promoting genes, including Cyclin D1, Cyclin E1, cyclin dependent kinase 6 (CDK6) and minichromosome maintenance 2 (MCM2), by targeting the stem–loop structure in the 3′ untranslated region (3’UTR) of mRNAs via its ROQ domain, leading to the downregulation of cell cycle–promoting mRNAs. Conclusions Our findings demonstrated that Roquin1 is a novel breast tumor suppressor and could induce G1/S cell cycle arrest by selectively downregulating the expression of cell cycle–promoting genes, which might be a potential molecular target for breast cancer treatment.

• Publisher: BioMed Central,Springer Nature B.V
• Subject: A549 Cells / Adenoviruses / Animals / Apoptosis / Biomedical and Life Sciences / Biomedicine / Breast cancer / Breast Neoplasms - genetics / Breast Neoplasms - metabolism / Breast Neoplasms - pathology / Cancer Research / Cell cycle / Cell growth / Cell Line, Tumor / Cell Proliferation - physiology / Down-Regulation / Female / G1 Phase Cell Cycle Checkpoints - genetics / Genes / Genes, Tumor Suppressor / Humans / Immunology / Kinases / Laboratory animals / MCF-7 Cells / Mice / Mice, Inbred BALB C / Mice, Nude / Oncology / Ontology / Plasmids / Proteins / RNA, Messenger - genetics / RNA, Messenger - metabolism / RNA-Binding Proteins - genetics / RNA-Binding Proteins - metabolism / S Phase Cell Cycle Checkpoints - genetics / Software / Tumorigenesis / Tumors / Ubiquitin-Protein Ligases - genetics / Ubiquitin-Protein Ligases - metabolism